{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:51:40Z","timestamp":1786495900493,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>An increasing number of studies have suggested that the important role of vasoactive peptides, such as pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) and calcitonin gene-related peptide (CGRP), in the pathophysiology of migraine seems undeniable in adults, but studies in pediatric migraine patients remain scarce. We prospectively investigated CGRP and PACAP-38 plasma levels in children with migraine during ictal and interictal periods and compared the results between migraine patients with aura and without aura. We were the first to explore the diagnostic value of a combination of CGRP and PACAP-38.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seventy-six migraine patients aged 4\u201318\u2009years and seventy-seven age-matched healthy children were included in the study. Plasma vasoactive peptides were measured using the enzyme-linked immunosorbent assay (ELISA). Differences and correlations of groups were analyzed using the independent samples t-test, analysis of variance (ANOVA), Mann-Whitney U test, and multiple linear regression. We also performed logistic regression and receiver operating characteristic curve (ROC) analyses to evaluate the diagnostic value of CGRP and PACAP-38 in pediatric migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PACAP-38 and CGRP levels in migraine patients during the ictal and interictal periods were higher than those in controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). PACAP-38 and CGRP levels in migraine patients with aura and without aura were higher than those in controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). PACAP-38 and CGRP were independent risk factors in diagnosing pediatric migraine (adjusted OR (PACAP-38) =1.331, 95% CI: 1.177\u20131.506, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; adjusted OR (CGRP)\u2009=\u20091.113, 95% CI: 1.064\u20131.165, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Area Under Curve (AUC) comparison: Combination (0.926)\u2009&gt;\u2009CGRP (0.869)\u2009&gt;\u2009PACAP-38 (0.867).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study found almost the same changes in CGRP and PACAP levels in pediatric migraine, suggesting that CGRP and PACAP-38 may work together to play an integral role in pediatric migraine. Higher CGRP levels were found in the ictal phase than in the interictal phase and with aura group than without aura group, indicating that CGRP may take part in the formation of pain and aura. Moreover, ROC and logistic regression analyses suggested that CGRP and PACAP-38 are good indicators to diagnose pediatric migraine, and the combination of CGRP and PACAP-38 was valuable in diagnosing pediatric migraine and differentiating pediatric migraine from non-migraine headaches.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study has been registered at the Chinese Clinical Trial Registry (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/edit.aspx?pid=65917&amp;htm=4\">ChiCTR2100043157<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-022-01435-7","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T12:22:43Z","timestamp":1655122963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["CGRP and PACAP-38 play an important role in diagnosing pediatric migraine"],"prefix":"10.1186","volume":"23","author":[{"given":"Junhui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"5","key":"1435_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/head.13275","volume":"58","author":"M Bonafede","year":"2018","unstructured":"Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P (2018) Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache. 58(5):700\u2013714. https:\/\/doi.org\/10.1111\/head.13275","journal-title":"Headache."},{"issue":"9406","key":"1435_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0140-6736(04)15440-8","volume":"363","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD (2004) Migraine. Lancet 363(9406):381\u2013391. https:\/\/doi.org\/10.1016\/S0140-6736(04)15440-8","journal-title":"Lancet"},{"issue":"10258","key":"1435_CR3","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 diseases and injuries collaborators","year":"2020","unstructured":"GBD 2019 diseases and injuries collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019 [published correction appears in Lancet. 2020 Nov 14;396(10262):1562]. Lancet. 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet."},{"issue":"5","key":"1435_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1046\/j.1468-2982.2000.00076.x","volume":"20","author":"SR Lu","year":"2000","unstructured":"Lu SR, Fuh JL, Juang KD, Wang SJ (2000) Migraine prevalence in adolescents aged 13-15: a student population-based study in Taiwan. Cephalalgia. 20(5):479\u2013485. https:\/\/doi.org\/10.1046\/j.1468-2982.2000.00076.x","journal-title":"Cephalalgia."},{"issue":"4","key":"1435_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1526-4610.2011.02001.x","volume":"52","author":"YI Rho","year":"2012","unstructured":"Rho YI, Chung HJ, Lee KH et al (2012) Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache. 52(4):592\u2013599. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.02001.x","journal-title":"Headache."},{"issue":"1","key":"1435_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s10194-019-1062-4","volume":"20","author":"T Takeshima","year":"2019","unstructured":"Takeshima T, Wan Q, Zhang Y et al (2019) Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain 20(1):111. Published 2019 Dec 5. https:\/\/doi.org\/10.1186\/s10194-019-1062-4","journal-title":"J Headache Pain"},{"key":"1435_CR7","doi-asserted-by":"publisher","unstructured":"(2018) Headache classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia:\u00a0Sage Publications. 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"6","key":"1435_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/dmcn.12679","volume":"57","author":"V Raieli","year":"2015","unstructured":"Raieli V, Pitino R, Giordano G et al (2015) Migraine in a pediatric population: a clinical study in children younger than 7 years of age. Dev Med Child Neurol 57(6):585\u2013588. https:\/\/doi.org\/10.1111\/dmcn.12679","journal-title":"Dev Med Child Neurol"},{"issue":"6123","key":"1435_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y et al (2013) Spreading depression triggers headache by activating neuronal Panx1 channels [published correction appears in science. 2015 Oct 2;350(6256):aad5166] [published correction appears in science. 2015 Nov 20;350(6263):921]. Science. 339(6123):1092\u20131095. https:\/\/doi.org\/10.1126\/science.1231897","journal-title":"Science."},{"issue":"11","key":"1435_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nrneurol.2013.192","volume":"9","author":"AC Charles","year":"2013","unstructured":"Charles AC, Baca SM (2013) Cortical spreading depression and migraine. Nat Rev Neurol 9(11):637\u2013644. https:\/\/doi.org\/10.1038\/nrneurol.2013.192","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1435_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie SJ, Kodji X, Brain SD (2014) Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev 94(4):1099\u20131142. https:\/\/doi.org\/10.1152\/physrev.00034.2013","journal-title":"Physiol Rev"},{"issue":"21","key":"1435_CR12","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1111\/bph.14053","volume":"175","author":"T Sundrum","year":"2018","unstructured":"Sundrum T, Walker CS (2018) Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: implications for migraine. Br J Pharmacol 175(21):4109\u20134120. https:\/\/doi.org\/10.1111\/bph.14053","journal-title":"Br J Pharmacol"},{"key":"1435_CR13","doi-asserted-by":"publisher","first-page":"174480691882045","DOI":"10.1177\/1744806918820452","volume":"15","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Han X, Wu H et al (2019) Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: relevant to migraine. Mol Pain 15:1744806918820452. https:\/\/doi.org\/10.1177\/1744806918820452","journal-title":"Mol Pain"},{"issue":"6","key":"1435_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.npep.2013.10.010","volume":"47","author":"EA Kaiser","year":"2013","unstructured":"Kaiser EA, Russo AF (2013) CGRP and migraine: could PACAP play a role too? Neuropeptides. 47(6):451\u2013461. https:\/\/doi.org\/10.1016\/j.npep.2013.10.010","journal-title":"Neuropeptides."},{"issue":"Pt 1","key":"1435_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 132(Pt 1):16\u201325. https:\/\/doi.org\/10.1093\/brain\/awn307","journal-title":"Brain."},{"issue":"1","key":"1435_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-017-0821-3","volume":"18","author":"H Ashina","year":"2017","unstructured":"Ashina H, Guo S, Vollesen ALH, Ashina M (2017) PACAP38 in human models of primary headaches. J Headache Pain 18(1):110. Published 2017 Nov 23. https:\/\/doi.org\/10.1186\/s10194-017-0821-3","journal-title":"J Headache Pain"},{"issue":"1","key":"1435_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","volume":"19","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L, Tajti J, Szal\u00e1rdy L, V\u00e9csei L (2018) PACAP and its role in primary headaches. J Headache Pain 19(1):21. Published 2018 Mar 9. https:\/\/doi.org\/10.1186\/s10194-018-0852-4","journal-title":"J Headache Pain"},{"issue":"4","key":"1435_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/0333102416644435","volume":"37","author":"AL Vollesen","year":"2017","unstructured":"Vollesen AL, Guo S, Ashina M (2017) PACAP38 dose-response pilot study in migraine patients. Cephalalgia. 37(4):391\u2013395. https:\/\/doi.org\/10.1177\/0333102416644435","journal-title":"Cephalalgia."},{"issue":"11","key":"1435_CR19","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S1474-4422(15)00244-6","volume":"14","author":"J Pascual","year":"2015","unstructured":"Pascual J (2015) CGRP antibodies: the holy grail for migraine prevention? Lancet Neurol 14(11):1066\u20131067. https:\/\/doi.org\/10.1016\/S1474-4422(15)00244-6","journal-title":"Lancet Neurol"},{"issue":"4","key":"1435_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1474-4422(16)00040-5","volume":"15","author":"ML Ramos","year":"2016","unstructured":"Ramos ML, Pascual J (2016) AMG 334 CGRP antibody for migraine: time to celebrate? Lancet Neurol 15(4):347\u2013349. https:\/\/doi.org\/10.1016\/S1474-4422(16)00040-5","journal-title":"Lancet Neurol"},{"issue":"6","key":"1435_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S1474-4422(17)30126-6","volume":"16","author":"MA Giamberardino","year":"2017","unstructured":"Giamberardino MA, Costantini R (2017) Challenging chronic migraine: targeting the CGRP receptor. Lancet Neurol 16(6):410\u2013411. https:\/\/doi.org\/10.1016\/S1474-4422(17)30126-6","journal-title":"Lancet Neurol"},{"issue":"3","key":"1435_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/0333102418768095","volume":"39","author":"R Messina","year":"2019","unstructured":"Messina R, Goadsby PJ (2019) CGRP - a target for acute therapy in migraine: clinical data. Cephalalgia. 39(3):420\u2013427. https:\/\/doi.org\/10.1177\/0333102418768095","journal-title":"Cephalalgia."},{"issue":"10203","key":"1435_CR23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S0140-6736(19)31947-6","volume":"394","author":"A Tessitore","year":"2019","unstructured":"Tessitore A, Russo A (2019) Is targeting CGRP the right pathway to prevent migraine? Lancet. 394(10203):984\u2013986. https:\/\/doi.org\/10.1016\/S0140-6736(19)31947-6","journal-title":"Lancet."},{"issue":"9","key":"1435_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S1474-4422(20)30282-9","volume":"19","author":"L Al-Hassany","year":"2020","unstructured":"Al-Hassany L, Van Den Brink AM (2020) Targeting CGRP in migraine: a matter of choice and dose. Lancet Neurol 19(9):712\u2013713. https:\/\/doi.org\/10.1016\/S1474-4422(20)30282-9","journal-title":"Lancet Neurol"},{"issue":"5","key":"1435_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1468-2982.1995.1505384.x","volume":"15","author":"V Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Floridi A et al (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 15(5):384\u2013390. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.1505384.x","journal-title":"Cephalalgia."},{"issue":"2","key":"1435_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0333102420957588","volume":"41","author":"F Hanci","year":"2021","unstructured":"Hanci F, Kilinc YB, Kilinc E, Turay S, Dilek M, Kabakus N (2021) Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods. Cephalalgia. 41(2):166\u2013175. https:\/\/doi.org\/10.1177\/0333102420957588","journal-title":"Cephalalgia."},{"issue":"4","key":"1435_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ncl.2019.07.009","volume":"37","author":"K Greene","year":"2019","unstructured":"Greene K, Irwin SL, Gelfand AA (2019) Pediatric migraine: an update. Neurol Clin 37(4):815\u2013833. https:\/\/doi.org\/10.1016\/j.ncl.2019.07.009","journal-title":"Neurol Clin"},{"issue":"8","key":"1435_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1468-2982.2008.01816.x","volume":"29","author":"PC Fan","year":"2009","unstructured":"Fan PC, Kuo PH, Chang SH, Lee WT, Wu RM, Chiou LC (2009) Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine. Cephalalgia. 29(8):883\u2013890. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01816.x","journal-title":"Cephalalgia."},{"issue":"14","key":"1435_CR29","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n E, Larrosa D, Ram\u00f3n C, Vega J, Mart\u00ednez-Camblor P, Pascual J (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology. 81(14):1191\u20131196. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a6cb72","journal-title":"Neurology."},{"issue":"3","key":"1435_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","volume":"106","author":"G Juhasz","year":"2003","unstructured":"Juhasz G, Zsombok T, Modos EA et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 106(3):461\u2013470. https:\/\/doi.org\/10.1016\/j.pain.2003.09.008","journal-title":"Pain."},{"issue":"4","key":"1435_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.22292","volume":"69","author":"MS Asghar","year":"2011","unstructured":"Asghar MS, Hansen AE, Amin FM et al (2011) Evidence for a vascular factor in migraine. Ann Neurol 69(4):635\u2013645. https:\/\/doi.org\/10.1002\/ana.22292","journal-title":"Ann Neurol"},{"issue":"1","key":"1435_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0306-3623(97)00078-5","volume":"30","author":"P Holzer","year":"1998","unstructured":"Holzer P (1998) Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30(1):5\u201311. https:\/\/doi.org\/10.1016\/s0306-3623(97)00078-5","journal-title":"Gen Pharmacol"},{"issue":"4","key":"1435_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0333102412439354","volume":"32","author":"M Baun","year":"2012","unstructured":"Baun M, Pedersen MH, Olesen J, Jansen-Olesen I (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia. 32(4):337\u2013345. https:\/\/doi.org\/10.1177\/0333102412439354","journal-title":"Cephalalgia."},{"issue":"1","key":"1435_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","volume":"16","author":"W He","year":"2019","unstructured":"He W, Long T, Pan Q et al (2019) Microglial NLRP3 inflammasome activation mediates IL-1\u03b2 release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation 16(1):78. Published 2019 Apr 10. https:\/\/doi.org\/10.1186\/s12974-019-1459-7","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1435_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/0304-3959(86)90244-7","volume":"25","author":"KD Davis","year":"1986","unstructured":"Davis KD, Dostrovsky JO (1986) Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain. 25(3):395\u2013401. https:\/\/doi.org\/10.1016\/0304-3959(86)90244-7","journal-title":"Pain."},{"issue":"6609","key":"1435_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/384560a0","volume":"384","author":"AM Strassman","year":"1996","unstructured":"Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 384(6609):560\u2013564. https:\/\/doi.org\/10.1038\/384560a0","journal-title":"Nature."},{"issue":"3 Pt 2","key":"1435_CR37","doi-asserted-by":"publisher","first-page":"H1095","DOI":"10.1152\/ajpheart.1994.266.3.H1095","volume":"266","author":"DM Colonna","year":"1994","unstructured":"Colonna DM, Meng W, Deal DD, Busija DW (1994) Calcitonin gene-related peptide promotes cerebrovascular dilation during cortical spreading depression in rabbits. Am J Phys 266(3 Pt 2):H1095\u2013H1102. https:\/\/doi.org\/10.1152\/ajpheart.1994.266.3.H1095","journal-title":"Am J Phys"},{"issue":"1\u20132","key":"1435_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0006-8993(94)91234-3","volume":"637","author":"M Wahl","year":"1994","unstructured":"Wahl M, Schilling L, Parsons AA, Kaumann A (1994) Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 637(1\u20132):204\u2013210. https:\/\/doi.org\/10.1016\/0006-8993(94)91234-3","journal-title":"Brain Res"},{"key":"1435_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brainres.2010.10.062","volume":"1368","author":"A Viggiano","year":"2011","unstructured":"Viggiano A, Viggiano E, Valentino I, Monda M, Viggiano A, De Luca B (2011) Cortical spreading depression affects reactive oxygen species production. Brain Res 1368:11\u201318. https:\/\/doi.org\/10.1016\/j.brainres.2010.10.062","journal-title":"Brain Res"},{"key":"1435_CR40","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","volume":"55","author":"AF Russo","year":"2015","unstructured":"Russo AF (2015) Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol 55:533\u2013552. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010814-124701","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"1435_CR41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1152\/jn.1998.79.2.964","volume":"79","author":"R Burstein","year":"1998","unstructured":"Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79(2):964\u2013982. https:\/\/doi.org\/10.1152\/jn.1998.79.2.964","journal-title":"J Neurophysiol"},{"issue":"1","key":"1435_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ana.10785","volume":"55","author":"R Burstein","year":"2004","unstructured":"Burstein R, Jakubowski M (2004) Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 55(1):27\u201336. https:\/\/doi.org\/10.1002\/ana.10785","journal-title":"Ann Neurol"},{"issue":"6\u20137","key":"1435_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/s0035-3787(05)85109-4","volume":"161","author":"R Burstein","year":"2005","unstructured":"Burstein R, Levy D, Jakubowski M (2005) Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine. Rev Neurol (Paris) 161(6\u20137):658\u2013660. https:\/\/doi.org\/10.1016\/s0035-3787(05)85109-4","journal-title":"Rev Neurol (Paris)"},{"issue":"308","key":"1435_CR44","doi-asserted-by":"publisher","first-page":"308ra157","DOI":"10.1126\/scitranslmed.aaa7557","volume":"7","author":"S Akerman","year":"2015","unstructured":"Akerman S, Goadsby PJ (2015) Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: relevance to migraine. Sci Transl Med 7(308):308ra157. https:\/\/doi.org\/10.1126\/scitranslmed.aaa7557","journal-title":"Sci Transl Med"},{"key":"1435_CR45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.neuroscience.2013.09.002","volume":"253","author":"A Shatillo","year":"2013","unstructured":"Shatillo A, Koroleva K, Giniatullina R et al (2013) Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system. Neuroscience. 253:341\u2013349. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.09.002","journal-title":"Neuroscience."},{"issue":"2","key":"1435_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1468-2982.2005.01008.x","volume":"26","author":"PA Battistella","year":"2006","unstructured":"Battistella PA, Fiumana E, Binelli M et al (2006) Primary headaches in preschool age children: clinical study and follow-up in 163 patients. Cephalalgia. 26(2):162\u2013171. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.01008.x","journal-title":"Cephalalgia."}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01435-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T12:22:45Z","timestamp":1655122965000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01435-7","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered at the Chinese Clinical Trial Registry (ChiCTR2100043157) and approved by the institutional ethics review board of Qilu Hospital of Shandong University (KYLL-202111-186-1). And when the participants were included in the study, we obtained written permission from the participants\u2019 guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}